Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD267 (TACI) Monoclonal Antibody (165609)
Mouse Monoclonal Antibody
$572.50 - $891.00
Specifications
Antigen | CD267 (TACI) |
---|---|
Clone | 165609 |
Concentration | 0.5 mg/mL |
Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
Applications | ELISA, Immunohistochemistry, Neutralization, Western Blot |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
PIMA523781
|
Invitrogen™
MA523781 |
500 μg |
Each for $891.00
|
|
|||||
PIMA523879
|
Invitrogen™
MA523879 |
100 μg |
Each for $572.50
|
|
|||||
Description
In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse TACI or recombinant human BCMA is observed. Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
Members in the TNF superfamily regulate immune responses and induce apoptosis. Two novel members in the TNF family were recently identified and designated BAFF/BLyS/TALL-1/THANK/zTNF4 and April/TALL-2, respectively. BAFF was characterized as a B cell activator since it induced B cell proliferation and immunoglobulin secretion. April regulates immunological and non-immunological cell growth. Three receptors, BCMA, TACI, and BAFF-R, for BAFF and April were recently identified. TACI, like BCMA, binds BAFF and April. TACI and its ligands regulate humoral immune responses, activate NF-kappa-B and c-jun N-terminal kinase, and are involved in B cell associated autoimmune diseases.Specifications
CD267 (TACI) | |
0.5 mg/mL | |
ELISA, Immunohistochemistry, Neutralization, Western Blot | |
Unconjugated | |
Mouse | |
RUO | |
PBS with 5% trehalose and No Preservative | |
O14836 | |
23495 | |
Mouse myeloma cell line NS0-derived recombinant human TACI/TNFRSF13B Ser2-Thr166. | |
Antibody |
165609 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Monoclonal | |
Lyophilized | |
IgG1 | |
Human | |
TNFRSF13B | |
1200009E08Rik; CD267; CVID; CVID2; IGAD2; NEWGENE_1595998; RYZN; TACI; TNF receptor superfamily member 13B; Tnfrsf13b; TNFRSF14B; transmembrane activator and calcium-modulating and cyclophilin ligand interactor; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor superfamily, member 13B | |
TNFRSF13B | |
Primary | |
Protein A/G |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title